A new histopathology software model could allow physicians to examine and reconstruct 3D images of disease-state tissue at a cellular level, thanks to the work of researchers a the University of Leeds in the United Kingdom.

Researchers at Stanford believe they have developed a nanoparticle solution that will aid physicians in the imaging and treatment of the most aggressive brain tumors, according to a study in Nature Medicine.

The promise of FDA-approved drugs for the diagnosis of Alzheimer's disease via diagnostic imaging led to a (potentially) billion-dollar payday for Bayer Pharma, which sold its molecular imaging development portfolio to Piramal Healthcare of Mumbai, India on Sunday.

It’s more than a truism to discuss mobile computing as the next horizon in the delivery of health care. Today, the achievements of such systems are measured in degrees of eventuality, rather than possibility; their potentials are gauged in whens, not ifs.

In 2007, CMS implemented a new program aimed at eliminating fraud and abuse: the use of Medicare recovery audit contractors (RACs). Under the RAC program, independent contractors look for improper Medicare payments in exchange for a percentage of the overpaid or underpaid dollars discovered, resulting in a high level of scrutiny for Medicare

Over the past few years, hospitals have been acquiring imaging centers at a brisk pace. Hospital and imaging-center transactions require an independent opinion on fair market value to ensure regulatory compliance; a thorough fair-market analysis will incorporate macroeconomic industry trends, along with the facts and circumstances specific to the

Interventional-radiology departments are facing increasing demands to justify costs, measure outcomes, and prove value in a competitive clinical environment. Though they are often managed alongside their diagnostic-radiology counterparts, the reality is that interventional-radiology departments have more in common with cardiac catheterization,

Over the past year, I have written about some of the key indicators pointing to a maturing of the medical-imaging marketplace. Among these is the fact that consolidation is accelerating across virtually all sectors of the profession: radiology groups, hospitals, health systems, vendors, and payors. Consolidation not only is a factor that affects